Rebecca Dennison
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rebecca Dennison has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Juliet Alexandra Usher-Smith
Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
16 shared publications - Simon J. Griffin
Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
7 shared publications Juliet A. Usher-Smith
Department of Public Health and Primary Care, Primary Care Unit, University of Cambridge, Cambridge, UK
5 shared publications- Stephen Morris
University of Cambridge, Cambridge, UK
5 shared publications - Lily C. Taylor
The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
4 shared publications - Rebecca J. Ward
Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
3 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (9) , 1430-1438
Priorities for breast cancer risk assessment in UK women under age 50: a survey and discrete choice experiment
Background: National guidelines recommend English women between 30 and 49 years with moderate/high risk of breast cancer (BC) be offered screening and prevention interventions. Identification largely relies on family history-based criteria amongst women self-presenting in primary care. We aimed to understand the preference for different potential risk assessment strategies in this population. Methods: A cross-sectional survey including a discrete choice experiment. Risk assessments were defined using six attributes, including initiation strategy, eligibility for a full/detailed risk assessment, components of the risk assessment, including multifactorial risk assessment based on the BOADICEA/CanRisk model, and sensitivity. Coefficients from conditional logistic regression were used to estimate preference for different risk assessment approaches compared to current care. Results: Participants ( n = 893) preferred alternative approaches for risk assessments over current care, particularly where all eligible women were proactively invited and more above-average risk women were correctly identified. All but one of 21 risk assessment approaches was preferred, with the most favoured approaches having a probability of being preferred over current care >92%. Education level and ethnicity potentially impacted the strength of participant priorities. Conclusions: Offering multifactorial BC risk assessments to younger women in primary care, especially the most proactive and broad approaches, would be acceptable and preferred over current practice.
- 4 August 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (9) , 1430-1438
Open AccessPriorities for breast cancer risk assessment in UK women under age 50: a survey and discrete choice experiment
Background: National guidelines recommend English women between 30 and 49 years with moderate/high risk of breast cancer (BC) be offered screening and prevention interventions. Identification largely relies on family history-based criteria amongst women self-presenting in primary care. We aimed to understand the preference for different potential risk assessment strategies in this population. Methods: A cross-sectional survey including a discrete choice experiment. Risk assessments were defined using six attributes, including initiation strategy, eligibility for a full/detailed risk assessment, components of the risk assessment, including multifactorial risk assessment based on the BOADICEA/CanRisk model, and sensitivity. Coefficients from conditional logistic regression were used to estimate preference for different risk assessment approaches compared to current care. Results: Participants ( n = 893) preferred alternative approaches for risk assessments over current care, particularly where all eligible women were proactively invited and more above-average risk women were correctly identified. All but one of 21 risk assessment approaches was preferred, with the most favoured approaches having a probability of being preferred over current care >92%. Education level and ethnicity potentially impacted the strength of participant priorities. Conclusions: Offering multifactorial BC risk assessments to younger women in primary care, especially the most proactive and broad approaches, would be acceptable and preferred over current practice.
- Open Access
- 17 June 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (6) , 1-11
Evolving attitudes towards cancer screening: a 2024 update of UK population views
Background: This study assessed current population views about cancer screening in light of the Covid-19 pandemic, screening programme changes and new technological advances. Methods: UK adults (aged $$\ge$$ 18 years), recruited via the online platform, Prolific, completed a questionnaire about their views on cancer screening, using eight questions from a 2012 survey (weighted for age and sex, n = 603). We summarised participants’ views, explored associations with participant characteristics using logistic regression and compared 2024 and 2012 responses using Chi-square tests. Results: Public enthusiasm for cancer screening in the UK remained high with 93% believing routine screening is almost always beneficial, supported by strong beliefs that finding cancer early means treatment saves lives. Awareness of slow-growing cancers was modest at 51% but has increased since 2012. Nevertheless, most participants still wanted testing for slow-growing and untreatable cancer. Some believed they had received too few screening tests, particularly men, people from ethnic minority backgrounds and those with higher educational attainment. Conclusions: Our study showed that public appetite for screening persists even as awareness of slow-growing cancers increases, reflecting not only possible knowledge gaps but also trust, values and optimism about future treatments. Future research should explore these factors to support truly informed screening decisions.- 17 June 2026
- Published by Springer Nature in British Journal of Cancer
- Vol. 135 (6) , 1-11
Open AccessEvolving attitudes towards cancer screening: a 2024 update of UK population views
Background: This study assessed current population views about cancer screening in light of the Covid-19 pandemic, screening programme changes and new technological advances. Methods: UK adults (aged $$\ge$$ 18 years), recruited via the online platform, Prolific, completed a questionnaire about their views on cancer screening, using eight questions from a 2012 survey (weighted for age and sex, n = 603). We summarised participants’ views, explored associations with participant characteristics using logistic regression and compared 2024 and 2012 responses using Chi-square tests. Results: Public enthusiasm for cancer screening in the UK remained high with 93% believing routine screening is almost always beneficial, supported by strong beliefs that finding cancer early means treatment saves lives. Awareness of slow-growing cancers was modest at 51% but has increased since 2012. Nevertheless, most participants still wanted testing for slow-growing and untreatable cancer. Some believed they had received too few screening tests, particularly men, people from ethnic minority backgrounds and those with higher educational attainment. Conclusions: Our study showed that public appetite for screening persists even as awareness of slow-growing cancers increases, reflecting not only possible knowledge gaps but also trust, values and optimism about future treatments. Future research should explore these factors to support truly informed screening decisions. - Open Access
- 5 March 2026
- Published by SAGE Publications in Journal of Medical Screening
- Vol. 33 (3) , 152-162
Public (un)willingness to trade-off benefits and harms in decisions about cancer screening: A discrete choice experiment
Objectives: To quantify the harms participants are willing to accept for varying benefits from cancer screening following provision of information. Methods: We conducted an online discrete choice experiment with two samples of the UK public. Attributes were number of cancer diagnoses and deaths prevented (benefits) and overdiagnoses, false positives and false negatives (harms) for a population who are/are not screened for an unspecified cancer over their lifetimes. After selecting the best-fitting conditional logistic regression model for each sample, we used latent class analysis to investigate preference heterogeneity and calculated the probability that each class/group would take up screening with different benefit and harm levels. Results: In total, 1018 participants completed the discrete choice experiment. Cancer deaths prevented was the most important attribute, followed by the number of false positively/negatively detected cancers; cancers prevented and overdiagnosed were deemed relatively unimportant. Three latent classes were identified. The largest class (approximately two-thirds) chiefly opted for screening, focusing on deaths prevented; this group would strongly prefer screening participation even with harms only (probability 76%–92%). Approximately a quarter of each sample traded off benefits and harms; this group would likely take up screening with outcomes like those of colorectal screening (68%–87%). Conclusions: A minority of the public express preferences for screening that are influenced by trading-off potential benefits/harms, but most have strong preferences for cancer screening, focusing on the associated reduction of cancer deaths. The findings emphasise public health responsibility in appraising or generating evidence on benefits and harms to support decisions about the introduction or modification of screening programmes.
- 5 March 2026
- Published by SAGE Publications in Journal of Medical Screening
- Vol. 33 (3) , 152-162
Open AccessPublic (un)willingness to trade-off benefits and harms in decisions about cancer screening: A discrete choice experiment
Objectives: To quantify the harms participants are willing to accept for varying benefits from cancer screening following provision of information. Methods: We conducted an online discrete choice experiment with two samples of the UK public. Attributes were number of cancer diagnoses and deaths prevented (benefits) and overdiagnoses, false positives and false negatives (harms) for a population who are/are not screened for an unspecified cancer over their lifetimes. After selecting the best-fitting conditional logistic regression model for each sample, we used latent class analysis to investigate preference heterogeneity and calculated the probability that each class/group would take up screening with different benefit and harm levels. Results: In total, 1018 participants completed the discrete choice experiment. Cancer deaths prevented was the most important attribute, followed by the number of false positively/negatively detected cancers; cancers prevented and overdiagnosed were deemed relatively unimportant. Three latent classes were identified. The largest class (approximately two-thirds) chiefly opted for screening, focusing on deaths prevented; this group would strongly prefer screening participation even with harms only (probability 76%–92%). Approximately a quarter of each sample traded off benefits and harms; this group would likely take up screening with outcomes like those of colorectal screening (68%–87%). Conclusions: A minority of the public express preferences for screening that are influenced by trading-off potential benefits/harms, but most have strong preferences for cancer screening, focusing on the associated reduction of cancer deaths. The findings emphasise public health responsibility in appraising or generating evidence on benefits and harms to support decisions about the introduction or modification of screening programmes.
- Open Access
- 13 November 2025
- Published by Wiley in Health Expectations
- Vol. 28 (6) , e70486
Assessing the Quality of Community Jury Deliberations in Online and In‐Person Community Juries Using a Deductive Coding Framework
Introduction: Community juries require participants to engage in group deliberations, seeking to reach a consensus or verdict on the research question(s). Community juries have traditionally taken place in‐person, although holding them online or in a hybrid format is increasingly common, particularly following the COVID‐19 pandemic. In order for the community jury method to be used successfully, it is crucial to ensure that the goals of the deliberative process are accomplished. Objective: To assess the quality of unfacilitated deliberation in community juries held either online or in‐person. Methods: We conducted a secondary analysis of three community juries exploring the public acceptability of novel cancer screening and referral policies informed by personal risk. Two juries were held online, and one was held in‐person. We analysed the deliberations via framework analysis, using a previously developed deductive coding framework that addresses the theoretical goals underlying the deliberative process. Participants also completed post‐jury surveys including questions relating to their experiences of the online or in‐person setting. Results: Nine participants attended the in‐person jury, and a total of 15 attended online. Both online and in‐person juries achieved all six deliberative goals to some extent with juries in both settings able to participate in successful deliberation and produce well‐informed recommendations from a societal perspective. Conclusion: These findings suggest that community juries delivered both online and in‐person have the potential to facilitate high‐quality deliberations, and both settings can be used to successfully conduct community juries. Patient or Public Contribution: Four PPI representatives, who represented people with different characteristics, including a personal history of cancer, were involved throughout this research. Their contribution included the formation of the research question for the funding application, design of participant‐facing aspects of the research, such as presentations used within the juries, and creation of lay summaries of findings.
- 13 November 2025
- Published by Wiley in Health Expectations
- Vol. 28 (6) , e70486
Open AccessAssessing the Quality of Community Jury Deliberations in Online and In‐Person Community Juries Using a Deductive Coding Framework
Introduction: Community juries require participants to engage in group deliberations, seeking to reach a consensus or verdict on the research question(s). Community juries have traditionally taken place in‐person, although holding them online or in a hybrid format is increasingly common, particularly following the COVID‐19 pandemic. In order for the community jury method to be used successfully, it is crucial to ensure that the goals of the deliberative process are accomplished. Objective: To assess the quality of unfacilitated deliberation in community juries held either online or in‐person. Methods: We conducted a secondary analysis of three community juries exploring the public acceptability of novel cancer screening and referral policies informed by personal risk. Two juries were held online, and one was held in‐person. We analysed the deliberations via framework analysis, using a previously developed deductive coding framework that addresses the theoretical goals underlying the deliberative process. Participants also completed post‐jury surveys including questions relating to their experiences of the online or in‐person setting. Results: Nine participants attended the in‐person jury, and a total of 15 attended online. Both online and in‐person juries achieved all six deliberative goals to some extent with juries in both settings able to participate in successful deliberation and produce well‐informed recommendations from a societal perspective. Conclusion: These findings suggest that community juries delivered both online and in‐person have the potential to facilitate high‐quality deliberations, and both settings can be used to successfully conduct community juries. Patient or Public Contribution: Four PPI representatives, who represented people with different characteristics, including a personal history of cancer, were involved throughout this research. Their contribution included the formation of the research question for the funding application, design of participant‐facing aspects of the research, such as presentations used within the juries, and creation of lay summaries of findings.
- Open Access
Risk-based innovations in cancer screening and diagnosis: a discrete choice experiment to explore priorities of the UK public
Objective To understand the importance and potential impact on uptake of different attributes of risk-based innovations in the context of risk-stratified healthcare for cancer screening and symptomatic diagnosis. Design The online survey comprised a discrete choice experiment (DCE) in which participants chose between two risk assessment options or to opt out of risk stratification. There were six attributes: test method, type (genetic or non-genetic), location, frequency, sensitivity and specificity. Participants were randomly allocated to consider the choice in an asymptomatic or symptomatic context. Setting Members of the public in the UK. Participants 1202 participants completed the DCE. Outcome measures Conditional logistic regression and latent class analysis informed modelling of predicted preferences for a range of innovations with different features. Results Overall, participants preferred risk assessments over opting out and prioritised sensitivity, with test method and specificity also important. Genetic and non-invasive tests were favoured. With sensitivity and specificity of 80% or better, participants would be more likely to take up a risk assessment than not. Comparing the asymptomatic and symptomatic contexts, 65% and 73% of participants would be very likely to participate regardless of the innovation used, and 29% and 13% of participants might participate depending on the method, sensitivity and specificity. A minority showed strong dislike of risk-based innovations, particularly within screening. Conclusions There are high levels of public support for risk-based innovations within risk-stratified cancer healthcare, especially for referral decision-making and using genetic and non-invasive tests. Optimising risk-based innovations is needed to engage those whose participation is contingent on test methods and performance metrics.
Open AccessRisk-based innovations in cancer screening and diagnosis: a discrete choice experiment to explore priorities of the UK public
Objective To understand the importance and potential impact on uptake of different attributes of risk-based innovations in the context of risk-stratified healthcare for cancer screening and symptomatic diagnosis. Design The online survey comprised a discrete choice experiment (DCE) in which participants chose between two risk assessment options or to opt out of risk stratification. There were six attributes: test method, type (genetic or non-genetic), location, frequency, sensitivity and specificity. Participants were randomly allocated to consider the choice in an asymptomatic or symptomatic context. Setting Members of the public in the UK. Participants 1202 participants completed the DCE. Outcome measures Conditional logistic regression and latent class analysis informed modelling of predicted preferences for a range of innovations with different features. Results Overall, participants preferred risk assessments over opting out and prioritised sensitivity, with test method and specificity also important. Genetic and non-invasive tests were favoured. With sensitivity and specificity of 80% or better, participants would be more likely to take up a risk assessment than not. Comparing the asymptomatic and symptomatic contexts, 65% and 73% of participants would be very likely to participate regardless of the innovation used, and 29% and 13% of participants might participate depending on the method, sensitivity and specificity. A minority showed strong dislike of risk-based innovations, particularly within screening. Conclusions There are high levels of public support for risk-based innovations within risk-stratified cancer healthcare, especially for referral decision-making and using genetic and non-invasive tests. Optimising risk-based innovations is needed to engage those whose participation is contingent on test methods and performance metrics.
- Open Access
- 27 February 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-13
Societal views on using risk-based innovations to inform cancer screening and referral policies: findings from three community juries
Background: Recent advances mean that innovations are emerging that enable better stratification of individuals based on their risk of cancer so that screening or diagnostic investigations can be targeted to those at greatest need. We explored the views of the public, from a societal perspective, of using such risk-based innovations to identify people’s cancer risk and allocating healthcare accordingly. Methods: We conducted three community juries, each with 7–9 participants. Participants were informed about the topic and potential novel risk-based innovations through a series of presentations from experts and discussions. Polygenic risk scores, geodemographic segmentation, continuous monitoring of biomarkers, minimally invasive tests, artificial intelligence analysis of medical records, and wearable devices were used as examples. The participants then deliberated over the research questions before reporting their verdicts on the acceptability of these novel data-based approaches in principle. Transcripts were analysed using codebook thematic analysis. Results: All juries found that the proposed risk-based approaches to cancer healthcare were, in general, acceptable. Primarily this was because the approaches would enable use of information in a positive and constructive way. However, there were a number of qualifiers or caveats. In particular, participants highlighted the necessity of using accurate and robust data with a well-evidenced association with cancer risk. They also expressed concerns about unintended consequences such as for insurance, scams or erosion of personal liberty, and the burden to participate in data collection across society. All agreed that opting-out must be straightforward. Conclusions: Informed members of the public supported the concept of using innovations to estimate cancer risk and inform healthcare. Their priorities for accuracy, data security, participation burden, and personal liberty and choice tended to overlap with those of developers and policymakers. Work to ready these innovations for implementation should continue, with the public’s priorities accounted for in their development and dissemination in order to address any unintended consequences upfront.
- 27 February 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-13
Open AccessSocietal views on using risk-based innovations to inform cancer screening and referral policies: findings from three community juries
Background: Recent advances mean that innovations are emerging that enable better stratification of individuals based on their risk of cancer so that screening or diagnostic investigations can be targeted to those at greatest need. We explored the views of the public, from a societal perspective, of using such risk-based innovations to identify people’s cancer risk and allocating healthcare accordingly. Methods: We conducted three community juries, each with 7–9 participants. Participants were informed about the topic and potential novel risk-based innovations through a series of presentations from experts and discussions. Polygenic risk scores, geodemographic segmentation, continuous monitoring of biomarkers, minimally invasive tests, artificial intelligence analysis of medical records, and wearable devices were used as examples. The participants then deliberated over the research questions before reporting their verdicts on the acceptability of these novel data-based approaches in principle. Transcripts were analysed using codebook thematic analysis. Results: All juries found that the proposed risk-based approaches to cancer healthcare were, in general, acceptable. Primarily this was because the approaches would enable use of information in a positive and constructive way. However, there were a number of qualifiers or caveats. In particular, participants highlighted the necessity of using accurate and robust data with a well-evidenced association with cancer risk. They also expressed concerns about unintended consequences such as for insurance, scams or erosion of personal liberty, and the burden to participate in data collection across society. All agreed that opting-out must be straightforward. Conclusions: Informed members of the public supported the concept of using innovations to estimate cancer risk and inform healthcare. Their priorities for accuracy, data security, participation burden, and personal liberty and choice tended to overlap with those of developers and policymakers. Work to ready these innovations for implementation should continue, with the public’s priorities accounted for in their development and dissemination in order to address any unintended consequences upfront.
- Open Access
- 12 February 2025
- Published by Frontiers Media SA in Frontiers in Cancer Control and Society
- Vol. 3, 1522609
The public are receptive to risk-based innovations: a multi-methods exploration of anticipated acceptability and uptake of novel technologies for cancer early detection in symptomatic and asymptomatic scenarios
Introduction: New technologies and innovations are emerging that enable stratification of individuals based on their risk of cancer and enable screening or diagnostic investigations to be targeted to those at greatest need. This study aimed to explore, in depth, attitudes of the UK public toward this concept; specifically, anticipated acceptability and uptake, including barriers and enablers toward uptake.Methods: A survey was completed independently by a representative population sample and alongside a researcher in think aloud interviews. Participants considered three of six exemplars of innovations that enable risk assessment: polygenic risk scores, geodemographic segmentation, continuous biomarker monitoring, minimally invasive tests, artificial intelligence analysis of medical records, and wearable devices. Questions about likelihood of taking up the risk assessment, acceptability of risk-stratified healthcare, and comfort about risk results being used within healthcare generally were set in asymptomatic then symptomatic scenarios. Descriptive statistics and multivariable logistic regression were used to explore differences between the exemplars and contexts and the impact of individual characteristics. Interviews were analyzed using codebook thematic analysis guided by the Theoretical Framework of Acceptability. Free-text comments were also analyzed thematically.Results: 999 participants completed the survey independently and 21 participants completed interviews. Most were extremely or somewhat likely to take up risk assessments, ranging from 62.0% for geodemographic segmentation to 85.2% for minimally invasive tests in the asymptomatic scenario, and from 64.2% for geodemographic segmentation to 94.0% for minimally invasive tests in the symptomatic scenario. Acceptability of using the exemplars within risk-stratified screening or referral pathways followed a similar pattern, as did comfort with the results being used widely. Qualitative analyses showed that the innovations and risk-based approach were viewed as proactive and logical. Tests requiring low burden were preferred, although most participants did not consider the burden of any of the innovations to be too high, particularly in the symptomatic context.Conclusions: Risk-based innovations for cancer early detection are intuitive. Study participants would be likely to engage and support their use for risk stratification, particularly for decisions about symptom investigations. These findings justify and promote ongoing research to develop these technologies and highlight features that increase public acceptability.
- 12 February 2025
- Published by Frontiers Media SA in Frontiers in Cancer Control and Society
- Vol. 3, 1522609
Open AccessThe public are receptive to risk-based innovations: a multi-methods exploration of anticipated acceptability and uptake of novel technologies for cancer early detection in symptomatic and asymptomatic scenarios
Introduction: New technologies and innovations are emerging that enable stratification of individuals based on their risk of cancer and enable screening or diagnostic investigations to be targeted to those at greatest need. This study aimed to explore, in depth, attitudes of the UK public toward this concept; specifically, anticipated acceptability and uptake, including barriers and enablers toward uptake.Methods: A survey was completed independently by a representative population sample and alongside a researcher in think aloud interviews. Participants considered three of six exemplars of innovations that enable risk assessment: polygenic risk scores, geodemographic segmentation, continuous biomarker monitoring, minimally invasive tests, artificial intelligence analysis of medical records, and wearable devices. Questions about likelihood of taking up the risk assessment, acceptability of risk-stratified healthcare, and comfort about risk results being used within healthcare generally were set in asymptomatic then symptomatic scenarios. Descriptive statistics and multivariable logistic regression were used to explore differences between the exemplars and contexts and the impact of individual characteristics. Interviews were analyzed using codebook thematic analysis guided by the Theoretical Framework of Acceptability. Free-text comments were also analyzed thematically.Results: 999 participants completed the survey independently and 21 participants completed interviews. Most were extremely or somewhat likely to take up risk assessments, ranging from 62.0% for geodemographic segmentation to 85.2% for minimally invasive tests in the asymptomatic scenario, and from 64.2% for geodemographic segmentation to 94.0% for minimally invasive tests in the symptomatic scenario. Acceptability of using the exemplars within risk-stratified screening or referral pathways followed a similar pattern, as did comfort with the results being used widely. Qualitative analyses showed that the innovations and risk-based approach were viewed as proactive and logical. Tests requiring low burden were preferred, although most participants did not consider the burden of any of the innovations to be too high, particularly in the symptomatic context.Conclusions: Risk-based innovations for cancer early detection are intuitive. Study participants would be likely to engage and support their use for risk stratification, particularly for decisions about symptom investigations. These findings justify and promote ongoing research to develop these technologies and highlight features that increase public acceptability.
- Open Access
- 19 July 2024
- Published by Wiley in Health Expectations
- Vol. 27 (4) , e14153
Understanding the Preferences and Considerations of the Public Towards Risk‐Stratified Screening for Colorectal Cancer: Insights From Think‐Aloud Interviews Based on a Discrete Choice Experiment
Context: Risk stratification has been suggested as a strategy for improving cancer screening. Any changes to existing programmes must be acceptable to the public.Objective: This study aimed to explore the preferences and considerations of individuals relating to the introduction of different risk‐based strategies to determine eligibility for colorectal cancer (CRC) screening.Study Design: Participants completed a discrete choice experiment (DCE) within online interviews. Nine conjoint‐analysis tasks were created, each with two potential CRC screening programmes. The attributes included personal risk of CRC, screening invitation strategy and impact. Participants chose between programmes while thinking aloud and sharing their thoughts. Transcripts were analysed using codebook thematic analysis.Participants: Twenty participants based in England aged 40–79 years without previous cancer history or medical expertise.Results: When choosing between programmes, participants first and primarily looked to prioritise saving lives. The harms associated with screening were viewed as a surprise but also felt by most to be inevitable; the benefits frequently outweighed, therefore, harms were considered less important. Risk stratification using individual characteristics was considered a nuanced approach to healthcare, which tended to be preferred over the age‐alone model. Detailed personal risk information could be taken more seriously than non‐personalised information to motivate behaviour change. Although it had minimal impact on decision‐making, not diverting resources for screening from elsewhere was valued. Individuals who chose not to provide health information were considered irresponsible, while it was important that those with no information to provide should not lose out.Conclusion: Risk‐stratified CRC screening is generally aligned with public preferences, with decisions between possible stratification strategies dominated by saving lives. Even if attributes including risk factors, risk stratification strategy and risk communication contributed less to the overall decision to select certain programmes, some levels more clearly fulfilled public values; therefore, all these factors should be taken into consideration when redesigning and communicating CRC screening programmes.Patient or Public Contribution: The primary data source for this study is interviews with 20 members of the public (current, past or future CRC screening invitees). Two public representatives contributed to planning this study, particularly the DCE.
- 19 July 2024
- Published by Wiley in Health Expectations
- Vol. 27 (4) , e14153
Open AccessUnderstanding the Preferences and Considerations of the Public Towards Risk‐Stratified Screening for Colorectal Cancer: Insights From Think‐Aloud Interviews Based on a Discrete Choice Experiment
Context: Risk stratification has been suggested as a strategy for improving cancer screening. Any changes to existing programmes must be acceptable to the public.Objective: This study aimed to explore the preferences and considerations of individuals relating to the introduction of different risk‐based strategies to determine eligibility for colorectal cancer (CRC) screening.Study Design: Participants completed a discrete choice experiment (DCE) within online interviews. Nine conjoint‐analysis tasks were created, each with two potential CRC screening programmes. The attributes included personal risk of CRC, screening invitation strategy and impact. Participants chose between programmes while thinking aloud and sharing their thoughts. Transcripts were analysed using codebook thematic analysis.Participants: Twenty participants based in England aged 40–79 years without previous cancer history or medical expertise.Results: When choosing between programmes, participants first and primarily looked to prioritise saving lives. The harms associated with screening were viewed as a surprise but also felt by most to be inevitable; the benefits frequently outweighed, therefore, harms were considered less important. Risk stratification using individual characteristics was considered a nuanced approach to healthcare, which tended to be preferred over the age‐alone model. Detailed personal risk information could be taken more seriously than non‐personalised information to motivate behaviour change. Although it had minimal impact on decision‐making, not diverting resources for screening from elsewhere was valued. Individuals who chose not to provide health information were considered irresponsible, while it was important that those with no information to provide should not lose out.Conclusion: Risk‐stratified CRC screening is generally aligned with public preferences, with decisions between possible stratification strategies dominated by saving lives. Even if attributes including risk factors, risk stratification strategy and risk communication contributed less to the overall decision to select certain programmes, some levels more clearly fulfilled public values; therefore, all these factors should be taken into consideration when redesigning and communicating CRC screening programmes.Patient or Public Contribution: The primary data source for this study is interviews with 20 members of the public (current, past or future CRC screening invitees). Two public representatives contributed to planning this study, particularly the DCE.
- Open Access
- 29 March 2024
- Published by Wiley in Diabetic Medicine
- Vol. 41 (6) , e15316
The effectiveness of pharmacological and lifestyle interventions to reduce the risk of diabetes and hyperglycaemia following gestational diabetes: A systematic review and meta‐analysis
Aims: To synthesize the available evidence to better understand the effectiveness of interventions to prevent or delay hyperglycaemia and Type 2 diabetes mellitus (T2DM) postnatally in women with current or previous gestational diabetes mellitus (GDM).Methods: We searched five databases up to December 2020 for primary peer‐reviewed articles reporting postpartum glycaemic outcomes in women with (previous) GDM following pharmacological or lifestyle intervention. Outcomes were relative risk of T2DM or continuous measures of glycaemia, change or at follow‐up. A minimum of two studies evaluating the same intervention‐outcome combination were needed to conduct meta‐analyses, otherwise studies were described narratively. Meta‐regression was used to evaluate whether associations varied by additional variables. We assessed risk of bias using the Critical Appraisal Skills Programme checklist. PROSPERO record CRD42018102380.Results: We included 31 studies in the review with a total sample size of 8624 participants, and 26 studies in meta‐analyses. Two‐thirds of studies followed up participants at 1 year or less. Pharmacological interventions were associated with reduced risk of T2DM (0.80 [95% CI 0.64–1.00], n = 6 studies), as were lifestyle interventions albeit with a smaller effect size (0.88 [95% CI 0.76–1.01], n = 12 studies). Dietary and physical activity interventions were associated with a small reduction in fasting plasma glucose, particularly in longer interventions, but inconsistent effects were seen for other continuous outcomes.Conclusions: Although possibly due to chance, interventions to reduce hyperglycaemia after GDM may be effective. Future research should improve understanding of how interventions affect glucose control and how to optimise interventions for this population.
- 29 March 2024
- Published by Wiley in Diabetic Medicine
- Vol. 41 (6) , e15316
Open AccessThe effectiveness of pharmacological and lifestyle interventions to reduce the risk of diabetes and hyperglycaemia following gestational diabetes: A systematic review and meta‐analysis
Aims: To synthesize the available evidence to better understand the effectiveness of interventions to prevent or delay hyperglycaemia and Type 2 diabetes mellitus (T2DM) postnatally in women with current or previous gestational diabetes mellitus (GDM).Methods: We searched five databases up to December 2020 for primary peer‐reviewed articles reporting postpartum glycaemic outcomes in women with (previous) GDM following pharmacological or lifestyle intervention. Outcomes were relative risk of T2DM or continuous measures of glycaemia, change or at follow‐up. A minimum of two studies evaluating the same intervention‐outcome combination were needed to conduct meta‐analyses, otherwise studies were described narratively. Meta‐regression was used to evaluate whether associations varied by additional variables. We assessed risk of bias using the Critical Appraisal Skills Programme checklist. PROSPERO record CRD42018102380.Results: We included 31 studies in the review with a total sample size of 8624 participants, and 26 studies in meta‐analyses. Two‐thirds of studies followed up participants at 1 year or less. Pharmacological interventions were associated with reduced risk of T2DM (0.80 [95% CI 0.64–1.00], n = 6 studies), as were lifestyle interventions albeit with a smaller effect size (0.88 [95% CI 0.76–1.01], n = 12 studies). Dietary and physical activity interventions were associated with a small reduction in fasting plasma glucose, particularly in longer interventions, but inconsistent effects were seen for other continuous outcomes.Conclusions: Although possibly due to chance, interventions to reduce hyperglycaemia after GDM may be effective. Future research should improve understanding of how interventions affect glucose control and how to optimise interventions for this population.
- Open Access
- 19 November 2023
- Published by Elsevier in Preventive Medicine
- Vol. 177, 107786
A discrete choice experiment to understand public preferences and priorities for risk-stratified bowel cancer screening programmes in the UK
- 19 November 2023
- Published by Elsevier in Preventive Medicine
- Vol. 177, 107786
Open AccessA discrete choice experiment to understand public preferences and priorities for risk-stratified bowel cancer screening programmes in the UK